MARKET

BIVI

BIVI

Biovie Inc
NASDAQ
1.940
+0.160
+8.99%
Pre Market: 1.811 -0.129 -6.64% 04:39 06/29 EDT
OPEN
1.740
PREV CLOSE
1.780
HIGH
1.960
LOW
1.740
VOLUME
60
TURNOVER
0
52 WEEK HIGH
10.90
52 WEEK LOW
1.060
MARKET CAP
14.63M
P/E (TTM)
-0.4484
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIVI last week (0615-0619)?
Weekly Report · 06/22 09:33
BioVie files $300M mixed securities shelf
TipRanks · 06/18 21:25
BioVie Files Prospectus To Offer Up To $300M In Securities
Benzinga · 06/18 21:23
BIOVIE - FILES TO OFFER UP TO $300 MLN IN SECURITIES - SEC FILING
Reuters · 06/18 21:22
Weekly Report: what happened at BIVI last week (0608-0612)?
Weekly Report · 06/15 09:33
Weekly Report: what happened at BIVI last week (0601-0605)?
Weekly Report · 06/08 09:31
BioVie posts corporate presentation spotlighting bezisterim longevity-focused therapy pipeline
PUBT · 06/02 14:20
Weekly Report: what happened at BIVI last week (0525-0529)?
Weekly Report · 06/01 09:33
More
About BIVI
BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-kB, and the associated neuroinflammation and insulin resistance, but not ERK and NFkB homeostatic functions (such as insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's orphan drug candidate BIV201, is being evaluated for Phase III clinical testing for the reduction of further decompensation in participants with liver cirrhosis and ascites.

Webull offers BioVie Inc stock information, including NASDAQ: BIVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIVI stock methods without spending real money on the virtual paper trading platform.